Contact Person : Kris Waterman; Last Date for the submission of abstract : Not Available ; Description : This meeting will cover strategies to accelerate and de-risk clinical development through better and earlier safety and POC models, the use of translational biomarkers and imaging, novel clinical trial design and patient selection, and collaboration.